Vanguard Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.47B Buy
9,850,631
+37,197
+0.4% +$9.88M 0.04% 434
2025
Q3
$2.82B Sell
9,813,434
-65,791
-0.7% -$17.6M 0.04% 391
2025
Q2
$2.59B Buy
9,879,225
+156,717
+2% +$38.2M 0.04% 401
2025
Q1
$2.26B Buy
9,722,508
+71,464
+0.7% +$17.3M 0.04% 421
2024
Q4
$2.21B Buy
9,651,044
+14,027
+0.1% +$3.22M 0.04% 433
2024
Q3
$2.15B Buy
9,637,017
+26,052
+0.3% +$5.73M 0.04% 437
2024
Q2
$1.96B Sell
9,610,965
-25,431
-0.3% -$5.17M 0.04% 442
2024
Q1
$2.11B Sell
9,636,396
-109,261
-1% -$24.1M 0.04% 427
2023
Q4
$2.22B Sell
9,745,657
-446,792
-4% -$93.9M 0.05% 392
2023
Q3
$2.05B Sell
10,192,449
-1,826,824
-15% -$385M 0.05% 383
2023
Q2
$2.49B Sell
12,019,273
-104,464
-0.9% -$20.3M 0.06% 344
2023
Q1
$2.39B Sell
12,123,737
-40,197
-0.3% -$8.27M 0.06% 348
2022
Q4
$2.46B Sell
12,163,934
-198,319
-2% -$38.8M 0.07% 323
2022
Q3
$2.18B Sell
12,362,253
-235,638
-2% -$48.2M 0.06% 333
2022
Q2
$2.54B Sell
12,597,891
-42,134
-0.3% -$8.98M 0.07% 288
2022
Q1
$2.86B Buy
12,640,025
+123,457
+1% +$29M 0.07% 302
2021
Q4
$3.38B Sell
12,516,568
-109,360
-0.9% -$27.1M 0.08% 263
2021
Q3
$3.05B Sell
12,625,928
-56,972
-0.4% -$14.4M 0.08% 269
2021
Q2
$3.01B Buy
12,682,900
+307,017
+2% +$70M 0.07% 284
2021
Q1
$2.71B Buy
12,375,883
+263,762
+2% +$52.9M 0.07% 290
2020
Q4
$2.12B Sell
12,112,121
-141,670
-1% -$24.5M 0.06% 344
2020
Q3
$1.98B Sell
12,253,791
-395,644
-3% -$62.7M 0.07% 310
2020
Q2
$1.81B Sell
12,649,435
-323,608
-2% -$44.8M 0.06% 322
2020
Q1
$1.41B Buy
12,973,043
+294,927
+2% +$42.5M 0.06% 338
2019
Q4
$1.84B Buy
12,678,116
+20,297
+0.2% +$2.93M 0.06% 341
2019
Q3
$1.83B Buy
12,657,819
+36,019
+0.3% +$5.26M 0.07% 315
2019
Q2
$1.87B Sell
12,621,800
-38,661
-0.3% -$5.39M 0.07% 301
2019
Q1
$1.66B Sell
12,660,461
-4,724
-0% -$582K 0.07% 324
2018
Q4
$1.37B Buy
12,665,185
+66,437
+0.5% +$8.9M 0.06% 345
2018
Q3
$1.88B Buy
12,598,748
+99,853
+0.8% +$15.2M 0.07% 278
2018
Q2
$1.93B Buy
12,498,895
+50,527
+0.4% +$7.63M 0.08% 253
2018
Q1
$1.73B Buy
12,448,368
+200,299
+2% +$29.4M 0.08% 286
2017
Q4
$1.68B Buy
12,248,069
+145,933
+1% +$19.3M 0.07% 304
2017
Q3
$1.57B Buy
12,102,136
+40,895
+0.3% +$5.45M 0.07% 301
2017
Q2
$1.6B Buy
12,061,241
+269,582
+2% +$33M 0.08% 282
2017
Q1
$1.45B Buy
11,791,659
+301,688
+3% +$35.7M 0.07% 302
2016
Q4
$1.27B Buy
11,489,971
+255,495
+2% +$28.4M 0.07% 317
2016
Q3
$1.33B Buy
11,234,476
+285,138
+3% +$33.6M 0.08% 282
2016
Q2
$1.23B Buy
10,949,338
+539,331
+5% +$58M 0.08% 284
2016
Q1
$1.05B Buy
10,410,007
+280,106
+3% +$26.9M 0.07% 323
2015
Q4
$1.08B Buy
10,129,901
+358,640
+4% +$37M 0.07% 293
2015
Q3
$911M Buy
9,771,261
+252,288
+3% +$26.1M 0.07% 326
2015
Q2
$991M Buy
9,518,973
+218,034
+2% +$22.7M 0.07% 324
2015
Q1
$1.01B Buy
9,300,939
+1,815,764
+24% +$187M 0.07% 324
2014
Q4
$694M Buy
7,485,175
+238,480
+3% +$21.1M 0.05% 429
2014
Q3
$633M Buy
7,246,695
+166,220
+2% +$15M 0.05% 437
2014
Q2
$623M Buy
7,080,475
+79,396
+1% +$6.88M 0.05% 437
2014
Q1
$591M Buy
7,001,079
+66,691
+1% +$5.32M 0.05% 427
2013
Q4
$544M Sell
6,934,388
-58,762
-0.8% -$5.01M 0.05% 432
2013
Q3
$596M Sell
6,993,150
-40,194
-0.6% -$3.39M 0.06% 376
2013
Q2
$605M Buy
+7,033,344
New +$584M 0.06% 344

Other funds holding LH

Vanguard Group's LH Position: Q4 2025 in Review

Vanguard Group increased its Labcorp (LH) stake by 0.38% in Q4 2025, buying an estimated $9.88M and bringing the position to 9,850,631 shares worth $2.47B. The position accounts for 0.04% of the portfolio, ranked #434.

Vanguard Group first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.38B in Q4 2021. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Vanguard Group held 9,850,631 shares of Labcorp worth $2.47B as of Q4 2025.
  • Vanguard Group bought 37,197 Labcorp shares in Q4 2025, an estimated $9.88M.
  • Labcorp made up 0.04% of Vanguard Group's portfolio in Q4 2025, its #434 holding.
  • Vanguard Group first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Labcorp position peaked at $3.38B in Q4 2021.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.